Glenmark to conduct trials of potential COVID-19 drug

As per the clinical trial protocol approved, 150 subjects with mild to moderate COVID-19 will be randomised in the study in a 1:1 ratio to Favipiravir with standard supportive care or standalone......

India eyes oil-for-drugs deal with Venezuela to recoup pharma cash

Like pharmaceutical companies globally - which used to enjoy a preferential exchange rate in Venezuela - Indian producers have been left badly stung by the collapse of the bolivar currency Indian......

Sensex, Nifty climb 1% as oil prices rally

The S&P BSE Sensex surged 267 points to end at 23,649 and the Nifty50 soared 83 points to close at 7,192. Benchmark indices climb for the second day amid a firm rally in the Asian equities as......

Rosier year-end seen for Indian pharma, thanks to faster US approvals

India's pharmaceutical industry is expected to see sales and profit growth accelerate in the second half of the year, thanks to a pickup in the pace of US. approvals for new drugs, offsetting any......